Deborah A. Smeltzer
Director/Miembro de la Junta en Andrea's Voice Foundation .
Perfil
Ms. Deborah A.
Smeltzer is on the Board of Directors at Andrea's Voice Foundation and Diaxonhit.
Ms. Smeltzer was previously employed as Chief Financial Officer & VP-Operations by Dynavax Technologies Corp., Vice President by Applera Corp., General Partner by Grotech Capital Group, Inc., Chief Financial Officer & Vice President by Serono Genetics Institute SA, a Member-Supervisory Board by Exonhit, and Vice President & GM-Genetic Analysis Business by Applied Biosystems, Inc.
She received her undergraduate degree from the University of California, Irvine, a graduate degree from the University of California, Irvine, and an MBA from Stanford University.
Cargos activos de Deborah A. Smeltzer
| Empresas | Cargo | Inicio |
|---|---|---|
| Andrea's Voice Foundation | Director/Miembro de la Junta | 01/01/2007 |
Antiguos cargos conocidos de Deborah A. Smeltzer.
| Empresas | Cargo | Fin |
|---|---|---|
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Director/Miembro de la Junta | 20/12/2012 |
| DYNAVAX TECHNOLOGIES CORPORATION | Director Financiero/CFO | 31/12/2009 |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Corporate Officer/Principal | 01/07/2008 |
Grotech Management Co.
 Grotech Management Co. Investment ManagersFinance Grotech Management Co (Grotech Management) is a venture capital firm founded in 1984 by Frank A. Adams. The firm is headquartered in Owings Mills, Maryland. | Corporate Officer/Principal | 01/01/1996 |
| EUROBIO SCIENTIFIC | Director/Miembro de la Junta | - |
Formación de Deborah A. Smeltzer.
| Stanford University | Masters Business Admin |
| University of California, Irvine | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| EUROBIO SCIENTIFIC | Health Technology |
| Empresas privadas | 6 |
|---|---|
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
Grotech Management Co.
Grotech Management Co. Investment ManagersFinance Grotech Management Co (Grotech Management) is a venture capital firm founded in 1984 by Frank A. Adams. The firm is headquartered in Owings Mills, Maryland. | Finance |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
| Andrea's Voice Foundation |
- Bolsa de valores
- Insiders
- Deborah A. Smeltzer
